Method for identifying and enriching cell specific target structures
Abstract
Identifying and concentrating cell-specific target structures (A), particularly for identifying cell-specific protein combination patterns (PCP) on the surface of cells and concentration of these cells, is new. Identifying and concentrating cell-specific target structures (A), in order to identify cell-specific protein combination patters on cell surfaces, is new. A heterologous cell mixture is applied to one or more surfaces of predetermined structure so that: (i) cells with appropriate (A) bind; (ii) unbound cells are removed from the surface; (iii) responsible for binding of cells are identified; (iv) cells having identified (A) are selected and concentrated; and (v) selected (A) are characterized biochemically.
Term
Term ended
Projected expiry passed 15 March 2021, 5.5 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
9 claims: 9 independent, 0 dependent
- 1A method for identifying and enriching cell-specific target structures, in particular for the identification of cell-specific protein combination patterns on the Surface of cells, and for enriching these cells, the method comprising the steps of:a) applying a heterogeneous cell mixture onto one or more surfaces with predefined structures, cells with appropriate target structures on the Surface or surfaces are bonded;b) removing the non-binding cells of the cell mixture from the surface or surfaces;c) identifying the cell-specific target structures, which of for the binding of the cells to are or the surfaces responsible;d) selection and enrichment of cells with identical cell-specific target structures on the surface or surfaces;ande) Biochemical characterization of the selected according to method step d) Target structures. Verfahren zur Identifizierung und Anreicherung von zellspezifischen Zielstrukturen, insbesondere zur Identifikation zellspezifischer Proteinkombinationsmuster auf der Oberfläche von Zellen und zur Anreicherung dieser Zellen, wobei das Verfahren folgende Schritte umfaßt: a) Aufbringen eines heterogenen Zellgemisches auf eine oder mehrere Oberflächen mit vordefinierten Strukturen, wobei Zellen mit entsprechenden Zielstrukturen an die Oberfläche oder die Oberflächen gebunden werden;b) Abführen der nicht-bindenden Zellen des Zellgemisches von der oder den Oberflächen;c) Identifizierung der zellspezifischen Zielstrukturen, die für die Bindung der Zellen an der oder den Oberflächen verantwortlich sind;d) Auswahl und Anreicherung von Zellen mit identischen zellspezifischen Zielstrukturen auf der oder den Oberflächen;unde) biochemische Charakterisierung der gemäß Verfahrensschritt d) ausgewählten Zielstrukturen.
- 2The method of claim 1, characterized,that the heterogeneous mixture of cells from human or animal tissue or human or animal body fluids is isolated or cultured cells is are. Verfahren nach Anspruch 1, dadurch gekennzeichnet,daß das heterogene Zellgemisch aus menschlichen oder tierischen Gewebe oder menschlichen oder tierischen Körperflüssigkeiten isoliert wird oder angezüchtete Zellen sind.
- 3Method according to one of the preceding claims, characterized, that the surface of a human or animal tissue section and / or Endothelial cells and / or protein chips and / or a pre-bred human or animal tissue piece. Verfahren nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet,daß die Oberfläche ein menschlicher oder tierischer Gewebeschnitt und/oder Endothelzellen und/oder Proteinchips und/oder ein angezüchtetes menschliches oder tierisches Gewebestück ist.
- 4Method according to one of the preceding claims, characterized,that the identification of cell-specific target structures by a method is performed that comprises the steps of:I) automated application of a reagent solution Y1 having at least one having marker molecule on the cell-specific target structure;II) exposing the reagent solution Y1 and automated detection of at least one Marking pattern of the labeled with the reagent solution Y1 target structure;III) removing the reagent solution Y1 before or after detecting the marking pattern and repeating steps I) and II) with further reagent solutions Yn (n = 2, 3 ... N), the other in each case at least one marker molecule and / or at least one exhibit marker molecule;andIV) Summarize each in step II) detected marker pattern to a complex molecular combination pattern of the cell-specific target structure. Verfahren nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet,daß die Identifizierung der zellspezifischen Zielstrukturen mit einem Verfahren durchgeführt wird, daß folgende Schritte umfaßt: I) Automatisiertes Aufbringen einer Reagenzlösung Y1, die mindestens ein Markiermolekül aufweist, auf die zellspezifische Zielstruktur;II) Einwirken der Reagenzlösung Y1 und automatisierte Detektion mindestens eines Markierungsmusters der mit der Reagenzlösung Y1 markierten Zielstruktur;III) Entfernen der Reagenzlösung Y1 vor oder nach der Detektion des Markierungsmusters und Wiederholung der Schritte I) und II) mit weiteren Reagenzlösungen Yn (n= 2, 3...N), die jeweils das mindestens eine Markiermolekül und/oder mindestens ein anderes Markiermolekül aufweisen;undIV) Zusammenfassen der jeweils in Schritt II) detektierten Markierungsmuster zu einem komplexen molekularen Kombinationsmuster der zellspezifischen Zielstruktur.
- 5Method according to one of the preceding claims, characterized,that the biochemical characterization of selected targets in accordance Method step e) by means of a molecule or molecule complex separation method, especially protein separation process occurs. Verfahren nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet,daß die biochemische Charakterisierung der ausgewählten Zielstrukturen gemäß Verfahrensschritt e) mittels eines Molekül- oder Molekülkomplextrennverfahrens, insbesondere Proteintrennverfahrens, erfolgt.
- 6A method according to claim 5, characterized,that the protein separation method is 2D gel electrophoresis. Verfahren nach Anspruch 5, dadurch gekennzeichnet,daß das Proteintrennverfahren eine 2D-Gel-Elektrophorese ist.
- 7Method according to one of the preceding claims, characterized,that after method step d) the following step is performed:dl) performing inhibition experiments with respect to one or more ingredients selected in step d), cell-specific target structures for recognition a binding hierarchy of components. Verfahren nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet,daß nach dem Verfahrensschritt d) folgender Verfahrensschritt durchgeführt wird: dl) Durchführung von Inhibitionsexperimenten bezüglich eines oder mehrerer Bestandteile der in Verfahrensschritt d) ausgewählten zellspezifischen Zielstrukturen zur Erkennung einer Bindungshierarchie der Bestandteile.
- 8A method according to claim 7, characterized,that the ingredients one or more proteins of a cell-specific protein combination pattern are. Verfahren nach Anspruch 7, dadurch gekennzeichnet,daß die Bestandteile einzelne oder mehrere Proteine eines zellspezifischen Proteinkombinationsmusters sind.
- 9The method of claim 1, characterized,that the following method steps are performed instead of method step e):f) automated application of a reagent solution Y1 having at least one having marker molecule, to the selected and enriched cell-specific Target structure;g) exposing the reagent solution Y1 and automated detection of at least one Marking pattern of the labeled with the reagent solution Y1 target structure;h) removing the reagent solution Y1 before or after detecting the marking pattern and repeating the steps f) and g) with further reagent solutions Yn (n = 2, 3 ... N), each of the at least one marker molecule and / or at least one other exhibit marker molecule;andi) combining the detected respectively in step g) marking pattern to a complex molecular combination pattern of selected and enriched cell-specific target structure. Verfahren nach Anspruch 1, dadurch gekennzeichnet,daß anstelle von Verfahrensschritt e) folgende Verfahrensschritte durchgeführt werden: f) Automatisiertes Aufbringen einer Reagenzlösung Y1, die mindestens ein Markiermolekül aufweist, auf die ausgewählte und angereicherte zellspezifische Zielstruktur;g) Einwirken der Reagenzlösung Y1 und automatisierte Detektion mindestens eines Markierungsmusters der mit der Reagenzlösung Y1 markierten Zielstruktur;h) Entfernen der Reagenzlösung Y1 vor oder nach der Detektion des Markierungsmusters und Wiederholung der Schritte f) und g) mit weiteren Reagenzlösungen Yn (n= 2, 3...N), die jeweils das mindestens eine Markiermolekül und/oder mindestens ein anderes Markiermolekül aufweisen;undi) Zusammenfassen der jeweils in Schritt g) detektierten Markierungsmuster zu einem komplexen molekularen Kombinationsmuster der ausgewählten und angereicherten zellspezifischen Zielstruktur.
Independent claims9
20 paragraphs, as filed
The present invention relates to a method for the identification and enrichment of cell-specific target structures, in particular for the identification of cell-specific protein combination patterns on the surface of cells and for the enrichment of these cells.
The identification of cell-specific target structures is of central importance in the Elucidation of cell-cell interactions, the countless effects within an organism may give rise to. In particular, knowledge disease-specific target structures is a crucial for the development of effective and at the same time less adverse effects Drug.
It is known that immune cells (lymphocytes), specific combinations of proteins, also protein combination patterns or shortly called PKM expressing that in a bond Endothelial cells of the blood vessels of the brain and muscle tissue are responsible. Other Combinations of proteins not lead other hand capable of binding to these endothelial cells. Surprisingly, these specific combinations are inter-individually constant and always have the same binding functions. It appears therefore in the specific Proteinkombinationsmustem a interindividual constant lymphocyte binding code to act the cell surface for organ-specific endothelial cell surface, of a represents cell-specific target structure. Cell-specific target structures may thus quite exhibit specific protein combination patterns.
Invasive tumor cells have specific protein combination patterns on their Cell surfaces that touch to a targeted, ie organ-selective invasive behavior. Such Protein combination patterns therefore represent targets for potential drugs.
but is sine qua non for the development of such highly selective drugs Understanding the molecular composition of these target structures.
A method for identifying target structures are known from the prior art known to the on the analysis of gene expression profiles of diseased tissues or cells as compared based on gene expression profiles of healthy tissues or cells, both Protein expression profiles and expression profiles of messenger ribonucleic acid (mRNA) Light on the appearance of new proteins, dysregulated or abnormally modified proteins to give in diseased tissues or cells (eg, in: F. Lottspeich / H.Zorbas; bioanalysis; Oxford University Press; Heidelberg, 1998).
However, these methods all start from cell homogenates, which usually thousands or Millions of cells are based, because only with the help of this cell amounts expression profiles of the above type can be created. In the cell homogenates the cells lie in more open form, so that the proteins or mRNA molecules using biochemical can be extracted and separated method.
These known methods are not suitable, protein combination patterns to identify, since the individual protein components of such a protein combination pattern by the generation of cell homogenates and by the subsequent extraction processes are completely separated and the essential information regarding their cell- and gewebetopologischen location is lost. can by destroying the cell compartments Furthermore, no information regarding the combinations of proteins within this Cell compartments and their relative topological relation obtained another.
Another disadvantage of the known method is that the preparation steps of Tissue or cells of their removal or extraction to the step of isolating or separation of proteins of a large number of variable external influences may be subject, which are difficult to control and unify.
Another disadvantage of the known method is, moreover, that no analysis on the is the single cell level feasible, so that differences between the individual cells with respect to their Protein combination patterns are undetectable. In addition, proteins can only small Amount present, will not be detected by the known methods. this concerns in particular proteins or specific protein combinations, for example, only in few, however, pathogenic, disease-specific cells vorkommmen.
The object of the invention is therefore to provide a method of the abovementioned type, by can be identified and enriched cell-specific protein combination patterns and by which the mentioned disadvantages of the prior art are overcome.
This object is achieved by an inventive method for identifying and Enhancement of cell-specific target structures, in particular for the identification cell-specific protein combination patterns on the surface of cells and for Enrichment of these cells with the features of claim 1.
Advantageous embodiments of the inventive method are in the dependent claims described.
An inventive method for identifying and enriching cell-specific Targets, in particular for the identification of cell-specific protein combination patterns on the surface of cells, and for enriching these cells, comprising the steps of: (A) applying a heterogeneous cell mixture onto one or more surfaces with predefined structures, cells with appropriate target structures on the surface or the surfaces to be bonded; (B) removing the non-binding cells of the Cell mixture from the surface or surfaces; (C) identifying the cell-specific Target structures, which are responsible for binding of the cells to the surface or surfaces; (D) selection and enrichment of cells with identical cell-specific target structures on the surface or surfaces; and (e) the biochemical characterization according to method step (D) selected targets. Thereby, it is possible that those cell-specific Target structures, especially protein combinations the surface of cells identified may be responsible for binding to predefined structures. moreover these cell-specific target structures such as single cell surfaces enriched are to then deliver biochemical analysis method. Thus, proteins that only present in small quantities, are enriched and analyzed. This concerns in particular Proteins or specific protein combinations, for example, only in a few, however, pathogenic, disease-specific cells vorkommmen. In this way, ie, cells one and the same type of function in relation to highly selective binding for further Analyzes of them expressed proteins provided. Advantageously, the biochemical characterization of selected and enriched targets under Method step e) by means of a molecule or molecule complex separation method, such as a Protein separation process, in particular a 2-D gel electrophoresis.
An embodiment for carrying out the process steps (a) to (b) of the invention includes the following part process: 1) input and applying the liquid, heterogeneous Cell mixture in a channel of an analysis apparatus and to a microscope slide with a fixed, a predefined structure contained surface; 2) removal of the non-binding Cells via a channel opening of the passage and collecting said material in a vessel; 3) Cooling of the slide by a slide thermostat, and 4) of the fixation on the Slides bound cells.
In an advantageous embodiment of the inventive method is the heterogeneous Cell mixture from human or animal tissue or human or animal Body fluids isolated or cultured cells are attached and the surface is a human or animal tissue section and / or endothelial cells and / or protein chips and / or a pre-bred human or animal tissue piece. This is a rapid and accurate identification of cell-specific target structures for the development of Medicines guaranteed.
In a further advantageous embodiment of the inventive method is the Identifying the cell-specific target structures with a method carried out, the comprising the steps of: (I) automated application of a reagent solution Y1, the comprises at least one marker molecule to the cell-specific target structure; (II) exposing the Reagent solution Y1 and automated detection of at least one marking pattern of having the reagent solution Y1 labeled target structure; (III) removing the reagent solution Y1 before or after detection of the marking pattern, and repeating steps (I) and (II) with further reagent solutions Yn (n = 2, 3 ... N), each of the at least one marker molecule and / or at least one other marker molecule; and (TV) Summarize respectively in step ii) the detected marker pattern to a complex molecular Combination patterns of cell-specific target structure. With this identification method rapid and accurate identification of cell-specific target structures such as protein combination patterns guarantees on cell surfaces.
In a further advantageous embodiment of the inventive method after the Step (d) the following method step is carried out: (dl) performing Inhibition experiments with respect to one or more components in process step (d) selected cell-specific target structures for detecting a binding hierarchy of Components, wherein the components of one or more proteins of a cell-specific Protein combination pattern are. This can be determined which of these proteins selective binding protein in the hierarchy are particularly relevant and which should not. relevant Proteins are targets for the development of highly selective drugs.
In a further advantageous embodiment of the inventive method instead of process step (e) the following steps carried out: (f) Automated Applying a reagent solution Y1 having at least one marker molecule, to selected and enriched cell-specific target structure; (G) exposing the reagent Y1 and automated detection of at least one marking pattern of the Reagent solution Y1 labeled target structure; (H) removing the reagent solution Y1 before or after the detection of the marking pattern, and repeating steps (f) and (g) with further Reagent solutions Yn (n = 2, 3 ... N), the or each said at least one marker molecule and / comprise at least one other marker molecule; and (i) combining the respective in Step (g) detected marker pattern to a complex molecular combination pattern of selected and enriched cell-specific target structure. According to enriched and selected cells of the same type permit now that the means Process steps (f) to (i) the cell-specific target structures still much more accurate can be investigated.
In summary, the inventive method allows, among other things, that for the Drug development relevant valid targets can be found efficiently, by biological Selektivitätsmechanimen for the identification of target structures underlying be placed.
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| SG106604A1 | Cited by | Singapore | Search report |
| EP0701130A2 | Cites | European Patent Office (EPO) | Search report |
| DE19709348A1 | Cites | Germany | Search report |
| US5437987A | Cites | United States of America | Search report |
| WO9318068A1 | Cites | World Intellectual Property Organization (WIPO) | Search report |
| WO9534817A1 | Cites | World Intellectual Property Organization (WIPO) | Search report |
13 members in 7 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 10014708 | Germany | A | |
| 10014708 | Germany | A | |
| 10014708 | Germany | – | |
| 10014708 | – | – | – |
| DE2000114708 | – | – | – |
Members13
| Document | Office | Kind | |
|---|---|---|---|
| EP1136823A2This record | European Patent Office (EPO) | A2 | |
| DE10014708A1 | Germany | A1 | |
| JP2001309800A | Japan | A | |
| US2001039024A1 | United States of America | A1 | |
| CN1332375A | China | A | |
| EP1136823A3 | European Patent Office (EPO) | A3 | |
| SG106604A1 | Singapore | A1 | |
| US6974675B2 | United States of America | B2 | |
| EP1136823B1 | European Patent Office (EPO) | B1 | |
| AT317125T | Austria | T | |
| ATE317125T1 | Austria | T1 | |
| DE50108823D1 | Germany | D1 | |
| CN100350247C | China | C |
59 legal events, as 6 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119 | R119 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Notification of lapseLapsedST | ST | FR | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Be: lapsedLapsedBERE | BERE | EP | |
| Name/firm changedPFA | PFA | CH | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Fr: translation filedET | ET | EP | |
| European patents designating ireland treated as always having been voidFD4D | FD4D | IE | |
| Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents actLapsedNLV1 | NLV1 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Gb: translation of ep patent filed (gb section 77(6)(a)/1977)GBT | GBT | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| New agentNV | NV | CH | |
| Corresponds to:REF | REF | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| European patents granted designating irelandGrantedLANGUAGE OF EP DOCUMENT: GERMANFG4D | FG4D | IE | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedNOT ENGLISHFG4D | FG4D | GB | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deletedORIGINAL CODE: EPIDOSDIGR1GRAJ | GRAJ | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Designation fees paidAT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TRAKX | AKX | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAL;LT;LV;MK;RO;SIAX | AX | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAL;LT;LV;MK;RO;SIAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1136823
- Publication, DOCDB
- 1136823
- Publication, EPODOC
- EP1136823
- Application
- 1106572
- Application, DOCDB
- 01106572
- Application, EPODOC
- EP20010106572
Titles3
- German
- Verfahren zur Identifizierung und Anreicherung von zellspezifischen Zielstrukturen
- English
- Method for identifying and enriching cell specific target structures
- French
- Méthode pour l'identification et l'enrichissement des structures cibles spécifiques aux cellules
Classification
- CPC, 5
- G01N33/6845
- G01N1/30
- G01N33/56966
- G01N33/68
- G01N33/6842
- IPC, 7
- C12N5 07
- C12N5 071
- C12Q1 02
- C12R1 91
- G01N1 30
- G01N33 569
- G01N33 68
Designated states26
- Contracting states, 20
- Austria
- Belgium
- Switzerland
- Cyprus
- Germany
- Denmark
- Spain
- Finland
- France
- United Kingdom
- Greece
- Ireland
- Italy
- Liechtenstein
- Luxembourg
- Monaco
- Netherlands (Kingdom of the)
- Portugal
- Sweden
- Türkiye
- Extension states, 6
- Albania
- Lithuania
- Latvia
- North Macedonia
- Romania
- Slovenia